Skip to content

Preoperative Chlorhexidine Gluconate (CHG) Cloth on Healthy Volunteers

Assessment of the Antimicrobial Efficacy of 2% CHG Cloth Preoperative Skin Preparation

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02526667
Enrollment
340
Registered
2015-08-18
Start date
2015-08-31
Completion date
2015-12-31
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Keywords

Preoperative surgical skin preparation

Brief summary

Evaluate the effects of Chlorhexidine Gluconate (CHG) cloth on the reduction of bacteria on the skin.

Detailed description

Examine the antimicrobial cloth effects on normal flora bacteria of the abdomen and groin areas post Chlorhexidine Gluconate (CHG) application.

Interventions

DRUGChlorhexidine gluconate

2% CHG solution on cloth

2% CHG solution

OTHERVehicle

Excipients of CHG product only

Sponsors

Medline Industries
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Males or Females * 18 years of age or older * Signed informed consent * Good Health * Six inches of abdomen and groin areas without tattoos, or skin disorders

Exclusion criteria

* Dermatological Conditions * Sensitivity to latex * Sensitivity to CHG

Design outcomes

Primary

MeasureTime frameDescription
Responder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin10 minutes, 6 hours, 8 hoursLog10 reduction in bacteria on the skin evaluated at 10 minutes, 6 hours and 8 hours after treatment. Responder rates (%) are the percentage of sites identified that produced a 2-Log and 3-Log reduction from baseline for abdomen and groin sites respectively.

Countries

Romania

Participant flow

Recruitment details

Upon achieving sufficient microbial growth prior to product application on either the abdomen, groin or both abdomen and groin regions,sites of the participant were then randomized to receive one or two products for evaluation for up to 4 sites. Differences in the number of participants is based on microbial qualification.

Pre-assignment details

The sites of the participant were tested for microbial activity after product application. In some instances, more than one product could have been applied to a participant but only one product per site (groin and/or abdomen sites). Up to 4 sites could be treated: 1) both groin and abdomen, 2) only the groin or 3) only the abdomen.

Participants by arm

ArmCount
CHG, Vehicle, Comparator CHG
Single applications of products. 3 min application for CHG and Vehicle. Comparator CHG applied according to instructions.
340
Total340

Baseline characteristics

CharacteristicCHG, Vehicle, Comparator CHG
Age, Categorical
<=18 years
1 Participants
Age, Categorical
>=65 years
24 Participants
Age, Categorical
Between 18 and 65 years
315 Participants
Age, Continuous38 years
Region of Enrollment
Romania
340 participants
Sex: Female, Male
Female
182 Participants
Sex: Female, Male
Male
158 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
EG005
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —— / —— / —
other
Total, other adverse events
0 / 2840 / 560 / 2810 / 2900 / 560 / 294
serious
Total, serious adverse events
0 / 2840 / 560 / 2810 / 2900 / 560 / 294

Outcome results

Primary

Responder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin

Log10 reduction in bacteria on the skin evaluated at 10 minutes, 6 hours and 8 hours after treatment. Responder rates (%) are the percentage of sites identified that produced a 2-Log and 3-Log reduction from baseline for abdomen and groin sites respectively.

Time frame: 10 minutes, 6 hours, 8 hours

Population: Number of participants involved in the analyses.

ArmMeasureGroupValue (NUMBER)
CHG 3 Min AbdomenResponder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin6 hours100 Percent of sites
CHG 3 Min AbdomenResponder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin8 hours99 Percent of sites
CHG 3 Min AbdomenResponder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin10 min78 Percent of sites
CHG 3 Min GroinResponder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin6 hours100 Percent of sites
CHG 3 Min GroinResponder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin8 hours100 Percent of sites
CHG 3 Min GroinResponder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin10 min84 Percent of sites
Vehicle AbdomenResponder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin8 hours96 Percent of sites
Vehicle AbdomenResponder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin10 min54 Percent of sites
Vehicle AbdomenResponder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin6 hours96 Percent of sites
Vehicle GroinResponder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin10 min56 Percent of sites
Vehicle GroinResponder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin6 hours100 Percent of sites
Vehicle GroinResponder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin8 hours100 Percent of sites
Comparator CHG AbdomenResponder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin8 hours98 Percent of sites
Comparator CHG AbdomenResponder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin10 min72 Percent of sites
Comparator CHG AbdomenResponder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin6 hours99 Percent of sites
Comparator CHG GroinResponder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin6 hours100 Percent of sites
Comparator CHG GroinResponder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin10 min73 Percent of sites
Comparator CHG GroinResponder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin8 hours100 Percent of sites

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026